6 completed, 1 active not recruiting, 1 terminated. 5 Phase 2, 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 3, Active not recruiting 1, Terminated 1 |
| Phase 1 | 3 | Completed 3 |
Follow Sarcoma, Ewing's: new trials by email Literature Review of Sarcoma, Ewing's trials Research Report on Sarcoma, Ewing's
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Find a Safe Dose and Show Early Clinical Activity of Weekly Nab-paclitaxel in Pediatric Patients With Recurrent/ Refractory Solid Tumors nab-paclitaxel - Neuroblastoma, Rhabdomyosarcoma | Phase 1 / Phase 2 | Completed | Celgene | 107 | 2013-12-04 | 2019-12-27 |
| Functional and Clinical Long-Term Outcome of Ewing Sarcoma Treatment Sarcoma, Ewing's | Completed | University Hospital Muenster | 950 | 2009-07-01 | 2016-04-28 | |
| A Study to Determine the Activity of Robatumumab (SCH 717454) in Participants With Relapsed Osteosarcoma or Ewing's Sarcoma (MK-7454-002/P04720) robatumumab - Osteosarcoma, Sarcoma, Ewing's | Phase 2 | Terminated | Merck Sharp & Dohme LLC | 219 | 2008-02-01 | 2018-08-23 |
| A Study of Pemetrexed in Children With Recurrent Cancer pemetrexed - Osteosarcoma, Medulloblastoma | Phase 2 | Completed | Eli Lilly and Company | 72 | 2007-09-01 | 2011-02-25 |
| Trial of Dasatinib in Advanced Sarcomas Dasatinib - Rhabdomyosarcoma, Malignant Peripheral Nerve Sheath Tumors | Phase 2 | Completed | Sarcoma Alliance for Research through Collaboration | 366 | 2007-05-01 | 2018-11-23 |
| Study Of Anti-IGF-IR CP-751,871 In Patients With Solid Tumors CP-751,871 - Sarcoma, Ewing's | Phase 1 | Completed | Pfizer | 65 | 2005-08-01 | 2013-12-17 |
| Radiation Therapy to Treat Musculoskeletal Tumors image-guided radiotherapy - Sarcoma, Ewing's, Rhabdomyosarcoma | Phase 2 | Active not recruiting | St. Jude Children's Research Hospital | 202 | 2003-01-10 | 2026-03-04 |
| A Pilot Study for the Treatment of Patients With Metastatic and High Risk Sarcomas and Primitive Neuroectodermal Tumors vincristine, adriamycin and cytoxan, alternating with ifosfamide VP-16 - Neuroectodermal Tumor, Primitive, Neuroepithelioma | Phase 1 | Completed | National Cancer Institute (NCI) | 120 | 1986-10-01 | 2008-03-04 |
Sarcoma, Ewing (8) · Osteosarcoma (4) · Rhabdomyosarcoma (4) · Sarcoma (4) · Neuroblastoma (2) · Bone Neoplasms (1) · Chondrosarcoma (1) · Chordoma (1) · Dermatofibrosarcoma (1) · Ependymoma (1) · Fibrosarcoma (1) · Gastrointestinal Stromal Tumors (1) · Giant Cell Tumor of Bone (1) · Hemangiopericytoma (1) · Histiocytoma (1)
Neoplasms by Histologic Type (8) · Neoplasms, Bone Tissue (8) · Neoplasms, Connective Tissue (8) · Neoplasms, Connective and Soft Tissue (8) · Neoplasms (7) · Neoplasms, Germ Cell and Embryonal (5) · Neoplasms, Nerve Tissue (5) · Myosarcoma (4) · Neoplasms, Glandular and Epithelial (4) · Neoplasms, Muscle Tissue (4) · Neoplasms, Neuroepithelial (4) · Osteosarcoma (4) · Sarcoma (4) · Neuroectodermal Tumors (3) · Neuroectodermal Tumors, Primitive (3)
130-nm albumin-bound paclitaxel (1) · Albumin-Bound Paclitaxel (1) · Cyclophosphamide (1) · Dasatinib (1) · Doxorubicin (1) · Pemetrexed (1) · Radiotherapy, Image-Guided (1) · Vincristine (1) · figitumumab (1) · robatumumab (1)
Celgene (1) · Eli Lilly and Company (1) · Merck Sharp & Dohme LLC (1) · National Cancer Institute (NCI) (1) · Pfizer (1) · Sarcoma Alliance for Research through Collaboration (1) · St. Jude Children's Research Hospital (1) · University Hospital Muenster (1)
United States (6) · United Kingdom (2) · Canada (1) · France (1) · Germany (1) · Italy (1) · Spain (1) · Switzerland (1)
Andreas Ranft, Dr. (1) · Ileana Elias, M.D. (1) · Matthew Krasin, MD (1) · Scott Schuetze, MD, PhD (1)
PMID 22682017, PMID 20036194, PMID 27362300, PMID 31401903, PMID 31987969, PMID 32554315